We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$663M
AUM Growth
-$835M
Cap. Flow
-$859M
Cap. Flow %
-129.52%
Top 10 Hldgs %
36.6%
Holding
684
New
251
Increased
107
Reduced
109
Closed
206

Sector Composition

Rank Sector Weight
1 Materials 20.16%
2 Technology 17.81%
3 Consumer Discretionary 13.64%
4 Healthcare 9.49%
5 Financials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
26
Apple
AAPL
$4.57T
$3.43M 0.52%
20,820
+8,272
+66% +$1.22M
IQV icon
27
IQVIA
IQV
$39.3B
$3.35M 0.51%
+16,855
New +$3.6M
CSL icon
28
Carlisle Companies
CSL
$15.4B
$3.09M 0.47%
+13,681
New +$3.33M
AA icon
29
Alcoa
AA
$13.2B
$3.06M 0.46%
+71,813
New +$3.46M
CDW icon
30
CDW
CDW
$17B
$2.86M 0.43%
+14,667
New +$2.88M
PEP icon
31
PepsiCo
PEP
$190B
$2.76M 0.42%
15,118
+5,187
+52% +$907K
SYF icon
32
Synchrony
SYF
$25.6B
$2.54M 0.38%
+87,263
New +$2.93M
JKHY icon
33
Jack Henry & Associates
JKHY
$11.1B
$2.4M 0.36%
+15,949
New +$2.66M
A icon
34
Agilent Technologies
A
$41.2B
$2.39M 0.36%
+17,286
New +$2.53M
PAYC icon
35
Paycom
PAYC
$9.69B
$2.37M 0.36%
+7,807
New +$2.35M
WAT icon
36
Waters Corp
WAT
$39.9B
$2.36M 0.36%
+7,632
New +$2.47M
GMED icon
37
Globus Medical
GMED
$11.2B
$2.36M 0.36%
+41,590
New +$2.67M
CBRE icon
38
CBRE Group
CBRE
$42.9B
$2.31M 0.35%
+31,667
New +$2.59M
PAGP icon
39
Plains GP Holdings
PAGP
$4.9B
$2.23M 0.34%
170,309
+70,276
+70% +$921K
ADBE icon
40
Adobe
ADBE
$105B
$2.22M 0.33%
+5,762
New +$2.05M
NDAQ icon
41
Nasdaq
NDAQ
$52.9B
$2.22M 0.33%
+40,579
New +$2.34M
VFC icon
42
VF Corp
VFC
$5.89B
$2.19M 0.33%
95,759
+38,687
+68% +$1.02M
HRL icon
43
Hormel Foods
HRL
$13.8B
$2.14M 0.32%
53,784
+30,590
+132% +$1.32M
ABT icon
44
Abbott
ABT
$187B
$2.14M 0.32%
+21,142
New +$2.23M
PAYX icon
45
Paychex
PAYX
$42.7B
$2.08M 0.31%
+18,120
New +$2.06M
MNST icon
46
Monster Beverage
MNST
$88.5B
$2.07M 0.31%
38,293
+29,323
+327% +$1.5M
MRSH
47
Marsh
MRSH
$91.5B
$2.05M 0.31%
12,315
+8,361
+211% +$1.39M
LI icon
48
Li Auto
LI
$12.7B
$2.04M 0.31%
+81,699
New +$1.93M
SPGI icon
49
S&P Global
SPGI
$120B
$2.03M 0.31%
+5,894
New +$2.07M
CL icon
50
Colgate-Palmolive
CL
$74.4B
$2.03M 0.31%
27,022
+12,065
+81% +$897K

Similar funds

Caxton Associates (New York)'s Q1 2023 Portfolio in Review

As of Q1 2023, Caxton Associates (New York) held 684 positions worth $663M, down 56% from $1.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Caxton Associates (New York) withdrew a net $859M in Q1 2023, closing 206 positions and reducing 109 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 0.33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Caxton Associates (New York) opened a new position in Advanced Micro Devices worth $14.8M.

  • Caxton Associates (New York)'s largest Q1 2023 buy was Advanced Micro Devices: 151,421 shares worth $14.8M.
  • Caxton Associates (New York) added most to Freeport-McMoran in Q1 2023, an estimated $123M increase.
  • Caxton Associates (New York)'s biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $541M.
  • Caxton Associates (New York) fully exited iShares Biotechnology ETF in Q1 2023, selling an estimated $152M.
  • Caxton Associates (New York)'s ten largest holdings make up 37% of its $663M portfolio in Q1 2023.
  • Caxton Associates (New York) opened 251 new positions and closed 206 in Q1 2023.
  • Caxton Associates (New York)'s portfolio value fell 56% quarter-over-quarter to $663M.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.